Complement C5 inhibitors
- Name
- Complement C5 inhibitors
- Accession Number
- DBCAT005928
- Description
Not Available
- Drugs
Drug Drug Description Eculizumab A recombinant humanized monoclonal antibody used to reduce the risk of hemolysis in paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS). Ravulizumab A monoclonal antibody used to treat paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis. Crovalimab A complement C5 inhibiting antibody used to treat paroxysmal nocturnal hemoglobinuria in adults and adolescents. - Drugs & Drug Targets
Drug Target Type Eculizumab Complement C5 target Ravulizumab Complement C5 target Crovalimab Complement C5 target